Depression diagnostic passes initial trial

A test developed by Ridge Diagnostics appeared in an initial clinical trial to successfully differentiate between depressed and healthy patients. Massachusetts General Hospital researchers conducted the trial with Ridge. They found that 33 of 36 patients who were already depressed tested positive for depression, but only 8 of 43 controls tested positive. In a second round, 31 of 34 depressed patients tested positive for depression. The test uses 9 biomarkers to gauge factors such as inflammation, the development and maintenance of neurons and the interaction between different structures in the brain involved with stress response. Details are published in the journal Molecular Psychiatry, and further testing is planned. Release

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.